0000950170-24-040164.txt : 20240402 0000950170-24-040164.hdr.sgml : 20240402 20240402161516 ACCESSION NUMBER: 0000950170-24-040164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240329 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tucker John H CENTRAL INDEX KEY: 0001303480 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38293 FILM NUMBER: 24814372 MAIL ADDRESS: STREET 1: INDEVUS PHARMACEUTICALS, INC. STREET 2: 99 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25 BURLINGTON MALL ROAD, SUITE 203 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 25 BURLINGTON MALL ROAD, SUITE 203 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 ownership.xml 4 X0508 4 2024-03-29 0001604950 scPharmaceuticals Inc. SCPH 0001303480 Tucker John H C/O SCPHARMACEUTICALS INC. 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 true true false false President and CEO false Stock Option (right to buy) 7.06 2024-03-29 4 A false 56025 0 A 2031-01-25 Common Stock 56025 56025 D On January 25, 2021, the Reporting Person was granted 112,050 options which were eligible to vest and become exercisable subject to certain performance conditions. On March 29, 2024, the Issuer's Board of Directors determined that the performance conditions for one half (1/2) of the grant were met, resulting in the vesting of 56,025 shares. The remaining 56,025 options were previously forfeited due to failure to meet certain performance conditions. /s/ John H. Tucker 2024-04-02